R&D investment Beijing Hanmi Pharmaceutical 2017-2022

Investment in research and development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)*

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2023

Region

South Korea

Survey time period

2017 to 2022

Supplementary notes

* Beijing Hanmi Pharmaceutical Co., Ltd. is a subsidiary of Hanmi Pharmaceutical Co., Ltd.

Figures have been rounded.

1,000 South Korean won equals 0.77 U.S. dollars or 0.71 euros as of July 2023.

The source did not provide a date of publication. The date used here is the access date.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Scandinavia "

Other statistics that may interest you Pharmaceutical industry in Scandinavia

Pharmaceutical sales

8

Patents and clinical trials

6

Trade

5

Key players

6

Further related statistics

10
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.